AI-Enhanced Neuromuscular Recovery Technology — one platform, multiple limbs.
A shared edge-AI engine, sensing fabric, and stimulation architecture — engineered into form factors for the arm, the lower leg, and the hand.
Upper-limb rehabilitation from shoulder to forearm — restoring reach, grip, and fine motor control.
Lower-limb support for the calf and shin — assisting gait, stability, and foot-drop correction.
A future addition — bringing proportional stimulation to the intrinsic muscles of the hand for dexterity and grasp recovery.
Electrode placement is mapped to the primary flexor and extensor groups of the upper arm, supporting controlled elbow flexion and extension.
Dry surface-EMG electrodes capture volitional muscle activation in real time, giving the AI continuous insight into the patient's intended movement.
Stimulation scales precisely to detected effort — reinforcing the patient's own intention rather than overriding it.
The edge-AI control unit sits low-profile at the top of the sleeve, housing the processor, stimulation driver, battery, and radio.
Printed conductive traces route every channel through the fabric itself — no exposed wiring, no external pods.
Clinic-grade therapy delivered safely at home, with sessions streamed to the cloud for clinician oversight.
Electrodes address the calf and anterior shin muscles that drive plantarflexion and dorsiflexion — central to balanced, stable stepping.
Stimulation is delivered at the muscles' motor points for efficient, comfortable recruitment at lower current.
A graduated compression structure holds electrodes in consistent contact through dynamic movement and weight-bearing.
sEMG sensing and EMS stimulation are woven into a single conformable stack, closing the loop between intent and assistance for gait and foot-drop support.
A continuous closed loop between intention and movement — captured for upper and lower limb rehabilitation.
A shared technology platform powers the entire family — engineered for real-time, adaptive, clinically grounded rehabilitation.
Sense-to-stimulate response inside the natural interpulse window of motor recruitment.
On-device inference interprets muscle intent locally — no cloud round-trip required.
Secure session streaming gives clinicians remote oversight of progress and adherence.
Built on an established 510(k) predicate — modernization, not reinvention.
Clinic-grade therapy delivered safely and comfortably in the home environment.
Stimulation continuously self-tunes to the patient's effort, fatigue, and recovery state.
The PREMS.AI platform builds on an established FDA 510(k) regulatory predicate — a modernization of cleared neuromuscular stimulation technology rather than a reinvention, compressing the path to market across the sleeve family.
Discuss the PathwayPartner with PREMS.AI to evaluate the Smart Sleeve family for your clinical program, research, or investment portfolio.
